Titre : Récepteur facteur neurotrophique ciliaire

Récepteur facteur neurotrophique ciliaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cholangitis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Récepteur facteur neurotrophique ciliaire : Questions médicales les plus fréquentes", "headline": "Récepteur facteur neurotrophique ciliaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Récepteur facteur neurotrophique ciliaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Récepteur facteur neurotrophique ciliaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs facteur croissance nerf", "url": "https://questionsmedicales.fr/mesh/D017475", "about": { "@type": "MedicalCondition", "name": "Récepteurs facteur croissance nerf", "code": { "@type": "MedicalCode", "code": "D017475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sous-unité alpha du récepteur du facteur neurotrophique ciliaire", "alternateName": "Ciliary Neurotrophic Factor Receptor alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D053739", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha du récepteur du facteur neurotrophique ciliaire", "code": { "@type": "MedicalCode", "code": "D053739", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.249" } } }, { "@type": "MedicalWebPage", "name": "Récepteur gp130 de cytokines", "alternateName": "Cytokine Receptor gp130", "url": "https://questionsmedicales.fr/mesh/D050822", "about": { "@type": "MedicalCondition", "name": "Récepteur gp130 de cytokines", "code": { "@type": "MedicalCode", "code": "D050822", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.500" } } }, { "@type": "MedicalWebPage", "name": "Sous-unité alpha du récepteur au facteur d'inhibition de la leucémie", "alternateName": "Leukemia Inhibitory Factor Receptor alpha Subunit", "url": "https://questionsmedicales.fr/mesh/D053680", "about": { "@type": "MedicalCondition", "name": "Sous-unité alpha du récepteur au facteur d'inhibition de la leucémie", "code": { "@type": "MedicalCode", "code": "D053680", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.750.400.550.250.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Récepteur facteur neurotrophique ciliaire", "alternateName": "Receptor, Ciliary Neurotrophic Factor", "code": { "@type": "MedicalCode", "code": "D020801", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Giovanni Tossetta", "url": "https://questionsmedicales.fr/author/Giovanni%20Tossetta", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } }, { "@type": "Person", "name": "Antonio Giordano", "url": "https://questionsmedicales.fr/author/Antonio%20Giordano", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } }, { "@type": "Person", "name": "Cuihong Jia", "url": "https://questionsmedicales.fr/author/Cuihong%20Jia", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37614, USA. Electronic address: jiac01@etsu.edu." } }, { "@type": "Person", "name": "Theo Hagg", "url": "https://questionsmedicales.fr/author/Theo%20Hagg", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, 37614, USA." } }, { "@type": "Person", "name": "Jessica Perugini", "url": "https://questionsmedicales.fr/author/Jessica%20Perugini", "affiliation": { "@type": "Organization", "name": "Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Case Report of Acute Liver Failure in a Child with Hepatitis a Virus and Epstein-Barr Virus Coinfection on the Background of Autoimmune Sclerosing Cholangitis.", "datePublished": "2024-09-26", "url": "https://questionsmedicales.fr/article/39355258", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/IMCRJ.S477802" } }, { "@type": "ScholarlyArticle", "name": "First two cases of literature: Caustic sclerosing cholangitis due to percutaneous treatment of hydatid liver disease causing liver transplantation.", "datePublished": "2024-02-12", "url": "https://questionsmedicales.fr/article/38487740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14744/hf.2023.2023.0031" } }, { "@type": "ScholarlyArticle", "name": "Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.", "datePublished": "2024-02-09", "url": "https://questionsmedicales.fr/article/38335208", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0298225" } }, { "@type": "ScholarlyArticle", "name": "Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC).", "datePublished": "2023-07-24", "url": "https://questionsmedicales.fr/article/37488782", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/his.15006" } }, { "@type": "ScholarlyArticle", "name": "Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36610465", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cca.2023.117219" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs peptidiques", "item": "https://questionsmedicales.fr/mesh/D018000" }, { "@type": "ListItem", "position": 7, "name": "Récepteur facteur croissance", "item": "https://questionsmedicales.fr/mesh/D017978" }, { "@type": "ListItem", "position": 8, "name": "Récepteurs facteur croissance nerf", "item": "https://questionsmedicales.fr/mesh/D017475" }, { "@type": "ListItem", "position": 9, "name": "Récepteur facteur neurotrophique ciliaire", "item": "https://questionsmedicales.fr/mesh/D020801" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Récepteur facteur neurotrophique ciliaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Récepteur facteur neurotrophique ciliaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Récepteur facteur neurotrophique ciliaire", "description": "Comment diagnostiquer une dysfonction du récepteur CNTF ?\nQuels examens sont utilisés pour évaluer le récepteur CNTF ?\nY a-t-il des biomarqueurs pour le récepteur CNTF ?\nLe diagnostic nécessite-t-il une biopsie ?\nQuels symptômes peuvent indiquer un problème avec le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Récepteur facteur neurotrophique ciliaire", "description": "Quels sont les symptômes d'une déficience en CNTF ?\nLa douleur neuropathique est-elle liée au CNTF ?\nPeut-on observer des troubles moteurs avec le CNTF ?\nLes troubles sensoriels sont-ils associés au CNTF ?\nY a-t-il des signes cliniques spécifiques au CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Récepteur facteur neurotrophique ciliaire", "description": "Peut-on prévenir les troubles liés au CNTF ?\nY a-t-il des mesures préventives spécifiques ?\nL'exercice régulier aide-t-il à prévenir les troubles du CNTF ?\nUne alimentation équilibrée peut-elle aider ?\nLe stress a-t-il un impact sur le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Récepteur facteur neurotrophique ciliaire", "description": "Quels traitements sont disponibles pour les troubles du CNTF ?\nLes thérapies géniques peuvent-elles aider le CNTF ?\nLes médicaments anti-inflammatoires sont-ils efficaces ?\nLa physiothérapie est-elle recommandée ?\nY a-t-il des traitements expérimentaux pour le CNTF ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Récepteur facteur neurotrophique ciliaire", "description": "Quelles complications peuvent survenir avec le CNTF ?\nLe CNTF peut-il entraîner des troubles cognitifs ?\nY a-t-il un risque de dépendance aux médicaments ?\nLes complications sont-elles réversibles ?\nLe CNTF peut-il affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Récepteur facteur neurotrophique ciliaire", "description": "Quels sont les facteurs de risque pour les troubles du CNTF ?\nL'âge est-il un facteur de risque pour le CNTF ?\nLe sexe influence-t-il le risque de troubles du CNTF ?\nLes infections peuvent-elles augmenter le risque ?\nLe mode de vie influence-t-il le risque de troubles ?", "url": "https://questionsmedicales.fr/mesh/D020801?mesh_terms=Cholangitis&page=82#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction du récepteur CNTF ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests neurologiques et des analyses génétiques." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le récepteur CNTF ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des IRM et des électromyogrammes peuvent être utilisés pour évaluer la fonction nerveuse." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs pour le récepteur CNTF ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour le récepteur CNTF." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il une biopsie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie n'est généralement pas nécessaire pour diagnostiquer les troubles liés au CNTF." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec le CNTF ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la faiblesse musculaire ou des douleurs neuropathiques peuvent indiquer un problème." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en CNTF ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, douleurs chroniques et troubles sensoriels." } }, { "@type": "Question", "name": "La douleur neuropathique est-elle liée au CNTF ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le CNTF joue un rôle dans la modulation de la douleur neuropathique." } }, { "@type": "Question", "name": "Peut-on observer des troubles moteurs avec le CNTF ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles moteurs peuvent survenir en raison d'une dysfonction du CNTF." } }, { "@type": "Question", "name": "Les troubles sensoriels sont-ils associés au CNTF ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles sensoriels peuvent être observés en cas de dysfonction du CNTF." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques spécifiques au CNTF ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'hypersensibilité ou l'engourdissement peuvent être spécifiques." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés au CNTF ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives spécifiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes nerveux et gérer les maladies chroniques peut aider." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les troubles du CNTF ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut renforcer les muscles et améliorer la santé nerveuse." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en nutriments favorise la santé nerveuse et musculaire." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le CNTF ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la fonction nerveuse et aggraver les symptômes." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles du CNTF ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies médicamenteuses et des interventions physiques." } }, { "@type": "Question", "name": "Les thérapies géniques peuvent-elles aider le CNTF ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur l'utilisation de thérapies géniques pour cibler le CNTF." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation et améliorer les symptômes liés au CNTF." } }, { "@type": "Question", "name": "La physiothérapie est-elle recommandée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut aider à améliorer la fonction musculaire et réduire la douleur." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour le CNTF ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme les thérapies biologiques, sont en cours d'évaluation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le CNTF ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent la progression des troubles neurologiques et la douleur chronique." } }, { "@type": "Question", "name": "Le CNTF peut-il entraîner des troubles cognitifs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir en raison de la dysfonction du CNTF." } }, { "@type": "Question", "name": "Y a-t-il un risque de dépendance aux médicaments ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains traitements peuvent entraîner une dépendance, nécessitant une surveillance." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Le CNTF peut-il affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles liés au CNTF peuvent significativement affecter la qualité de vie." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du CNTF ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des traumatismes." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour le CNTF ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de troubles liés au CNTF augmente avec l'âge." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de troubles du CNTF ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines études montrent que le sexe peut influencer le risque de troubles." } }, { "@type": "Question", "name": "Les infections peuvent-elles augmenter le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher des troubles liés au CNTF." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque de troubles ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } } ] } ] }

Sources (884 au total)

A Case Report of Acute Liver Failure in a Child with Hepatitis a Virus and Epstein-Barr Virus Coinfection on the Background of Autoimmune Sclerosing Cholangitis.

Fulminant hepatitis is a rare and severe form of acute liver failure (ALF) characterized by rapid and massive destruction of liver cells and associated with a high mortality rate. Infectious factors, ... A 2-year-old child was hospitalized on the 4th day of the disease with manifestations of jaundice and general intoxication. The examination revealed markers of active hepatitis A virus infection and E... The case is novel as regards the occurrence of two viral hepatitis with different modes of transmission on a background of unidentified liver disease....

Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.

An association between primary biliary cholangitis (PBC) and connective tissue diseases (CTDs) [rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren's syndrome (SS), systemic scleros... A two-sample Mendelian randomization (MR) analysis was performed to assess the causal relationship between PBC [Genome-Wide Association Study (GWAS) meta-analysis, 8021 cases/16498 controls], and SLE ... The IVW revealed that genetically predicted PBC increased the risk of SLE [odd's ratio (OR) = 1.43, 95% confidence interval (CI) 1.30-1.58, P < 0.001]), RA (OR = 1.09, 95%CI1.04-1.14, P<0.001), and SS... Our study provided new genetic evidence for a causal relationship between PBC and CTDs. PBC increased the risk of SLE, RA, and SS. Our findings highlighted the importance of active screening and inter...

Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC).

ATP-binding cassette transporters are important proteins in regulating bile constituent transport between hepatocytes and the bile canalicular system. Dysfunctional transporters lead to accumulation o... Retrospectively, formalin-fixed and paraffin-embedded liver biopsies, resections, and explants were selected to investigate the expression of ABCB1, ABCB4, ABCB11, ABCG5/8, and FXR1 using nanoString n... Our study concluded that altered ABCB4 expression is specifically seen in liver specimens of PSC patients. Therefore, quantitative ABCB4 analysis may be an additional useful tool for the histopatholog...

Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.

Anti-mitochondrial antibody (AMA) positivity is not always associated with primary biliary cholangitis (PBC). We aimed to determine the additional value of anti-sp100 or anti-gp210 antibody in AMA-pos... Patients (n = 190) and healthy donors (n = 50) were evaluated for AMA, anti-gp210 and anti-sp100 antibodies by ELISA. Antibody frequencies in cohorts and performance characteristics in some patients c... Of the patients (n = 190), 38.4% were AMA-positive (n = 73) and 61.6% AMA-negative (n = 117). Frequency of anti-sp100 or anti-gp210 antibody was 17.8%, 2.6%, and 0% in AMA-positive, AMA-negative and h... AMA-positive patients positive for anti-sp100 or anti-gp210 antibody were more likely to have a diagnosis of definite or probable PBC than those with AMA alone. Use of all tests is likely to improve c...

Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.

Treatment of primary biliary cholangitis (PBC) can improve the GLOBE score. We aimed to assess the association between changes in the GLOBE score (ΔGLOBE) and liver transplantation (LT)-free survival ... Among UDCA-treated patients within the Global PBC cohort, the association between ΔGLOBE (ΔGLOBE 0-1 : during the first year of UDCA, ΔGLOBE 1-2 : during the second year) and the risk of LT or death w... Overall, 3,775 UDCA-treated patients were included; 3,424 (90.7%) were female, the median age was 54.0 (interquartile range [IQR] 45.9-62.4) years, and the median baseline GLOBE score was 0.25 (IQR -0... UDCA-induced changes in the GLOBE score were significantly associated with LT-free survival in patients with PBC. While the relative risk reduction of LT or death was stable, the absolute risk reducti...

Bone Marrow and Peripheral Blood Mononuclear Cell Phenotype Changes after Cultivation and Autologous Infusion in Patients with Primary Biliary Cholangitis.

Primary biliary cholangitis (PBC) is a condition affecting the liver and immune system. In this study, the impact of autologous bone marrow-derived mononuclear cell (BM-MNC) transplantation on PBC pat... Sixteen eligible PBC patients participated at the National Scientific Medical Center in Astana, Kazakhstan, between 2017 and 2022, and BM-MNCs were harvested from their anterior iliac crest. After iso... Our findings revealed significant reductions in liver function tests after multiple transplantations. Flow cytometry analysis before and after a 24-hour culture and autologous BM-MNC infusion revealed... In summary, our study shows that BM-MNC transplantation in PBC patients leads to changes in immune cell populations and liver function. These findings suggest potential therapeutic applications of BM-...

Confronting the uncommon: Cholecystitis and cholangitis in a young adult arising from a bilobed gallbladder with subvesicle duct - A case report and review of literature.

Bilobed gallbladder is a rare congenital anomaly characterized by the duplication of the gallbladder. It presents a unique challenge for surgeons due to its infrequency and the potential for periopera... In our case report, we present the clinical details of a **23-year-old male** who presented with symptoms of acute cholecystitis and cholangitis. Preoperative imaging revealed a bilobed gallbladder, a... This case highlights considering bilobed gallbladder as a differential diagnosis in patients with cholecystitis or cholangitis is crucial. Surgeons should be vigilant about this anomaly when evaluatin... We understand precise imaging plays a pivotal role in guiding surgical planning. Detecting bilobed gallbladder preoperatively allows for better assessment of biliary structures and helps prevent bile ...